Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories. Together, they discuss recent news about virus activity and explore the value of collaboration in shaping innovative diagnostic strategies.
Due to the Christmas and New Year's holiday's (recognized on Sunday, December 25th, and Sunday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.
Terra Lasho is an assistant professor of medicine and principal research technologist for the Division of Hematology, where she works to help transform patient care from bench to bedside.
Effective Jan. 2, U.S. Customs and Border Protection will enhance the enforcement of the Centers for Disease Control and Prevention (CDC) requirements on the importation of biological specimens. Please include the CDC permit within your shipment. Failure to comply will result in your shipment being denied admissibility by U.S. Customs and Border Protection. If an entry is denied, the carrier is required to return or destroy the shipment.
This week's research roundup features: Expanding the platelet inventory to mitigate the impact of severe shortages
Topic highlights include: 'Untapped opportunity' as Mayo Clinic expands at-home care with paramedic program, RSV, flu and COVID-19: what you need to know about the viruses menacing Jacksonville area, ‘The situation in the hospitals is grim’: states face brutal virus fallout
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Medhat Askar, M.D., Ph.D., MSHPE, FRCPath, Professor of Pathology, Texas A&M College of Medicine, and Director of Clinical Services, National Marrow Donor Program (NMDP)/BeTheMatch. Listen as they discuss a very important topic this holiday season, the gift of organ donation.
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Drs. Pritt and Morice discuss how offering specialty testing for conditions like Stiff-Person Syndrome and Alpha-Gal helps to advance innovation and give patients the answers they need.
Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.
This week's research roundup features: In vitro activity of a hypochlorous acid-generating electrochemical bandage against yeast biofilms
New research by Robin Patel, M.D. and others at Mayo Clinic has found that the use of a “transcriptomic-based cellular deconvolution tool” called CIBERSORTx could help improve the detection of infectious and non-infectious causes of failed joint replacement surgeries.
Topic highlights include: HHS to end public health emergency for monkeypox in January, RSV, flu and COVID-19: What you need to know about the viruses menacing Jacksonville area, Negotiations continue ahead of Minnesota nurses strike deadline
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D., interim chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Drs. Pritt and Morice provide an update on respiratory illness in the United States and discuss what’s at stake for health care organizations and laboratories in this year’s omnibus spending bill.